Patents by Inventor Travis S. Bayer
Travis S. Bayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230200388Abstract: Disclosed herein are compounds or salts thereof, and compositions thereof, for increasing plant growth. Also disclosed are methods of increasing levels of plant nutrients using a compound, salt, or composition as disclosed herein. Also disclosed herein are kits comprising a compound, salt, or composition as described herein.Type: ApplicationFiled: June 3, 2021Publication date: June 29, 2023Applicant: Sound Agriculture CompanyInventors: Travis S. BAYER, Allison SCHWARTZ, Christian IBARRA, Shailaja CHADHA
-
Patent number: 10577358Abstract: Disclosed herein are plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.Type: GrantFiled: April 6, 2018Date of Patent: March 3, 2020Assignee: SOUND AGRICULTURE COMPANYInventors: Eric A. Davidson, Travis S. Bayer, Oliver Windram, Yonek Hleba
-
Publication number: 20190084970Abstract: Disclosed herein plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.Type: ApplicationFiled: April 6, 2018Publication date: March 21, 2019Inventors: Eric A. Davidson, Travis S. Bayer, Oliver Windram, Yonek Hleba
-
Patent number: 9994557Abstract: Disclosed herein plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.Type: GrantFiled: September 17, 2015Date of Patent: June 12, 2018Assignee: Asilomar Bio, Inc.Inventors: Eric A. Davidson, Travis S. Bayer, Oliver Windram, Yonek Hleba
-
Patent number: 9657279Abstract: The invention relates to systems and methods for production of compounds by yeast and other organisms. In one approach yeast engineered for production of a compound of commercial value is cultured together with a cellulosic bacteria, and the yeast uses a metabolic product produced by the bacteria as a carbon source. Methyl halides are an example of compounds that may be produced by this process. The invention also relates to production of organic compounds using genetically engineered organisms expressing a S-adenosylmethionine (SAM)-dependent methyl halide transferase. In one approach the organism, halides and a carbon source are incubated in a cultivation medium under conditions in which methyl halide is produced. The methyl halide may be collected and converted into non-halogenated organic molecules.Type: GrantFiled: November 26, 2008Date of Patent: May 23, 2017Assignee: The Regents of the University of CaliforniaInventors: Christopher A. Voigt, Travis S. Bayer
-
Publication number: 20160159780Abstract: Disclosed herein plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.Type: ApplicationFiled: September 17, 2015Publication date: June 9, 2016Inventors: Eric A. DAVIDSON, Travis S. BAYER, Oliver WINDRAM, Yonek HLEBA
-
Patent number: 9315862Abstract: The invention relates to trans-acting ligand-responsive nucleic acids and uses thereof. In particular, a ligand responsive nucleic acid comprises an effector domain and an aptamer domain that is responsive to a ligand.Type: GrantFiled: October 5, 2005Date of Patent: April 19, 2016Assignee: California Institute of TechnologyInventors: Christina D. Smolke, Travis S. Bayer
-
Patent number: 9309568Abstract: The invention relates to aptamer-regulated, ligand-responsive nucleic acids, or “ampliSwitches,” and uses thereof. Particular embodiments include a ligand-responsive nucleic acid that comprises a primer sequence domain and an aptamer domain that is responsive to a ligand.Type: GrantFiled: May 27, 2014Date of Patent: April 12, 2016Assignee: California Institute of TechnologyInventors: Christina D. Smolke, Travis S. Bayer
-
Publication number: 20150274690Abstract: Disclosed herein plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.Type: ApplicationFiled: October 24, 2014Publication date: October 1, 2015Inventors: Eric A. Davidson, Travis S. Bayer, Oliver Windram, Yonek Hleba
-
Patent number: 9040266Abstract: Disclosed is a process in which a recombinant organism, such as a yeast, expressing a heterologous S-adenosylmethionine (SAM)-dependent methyl halide transferase (MHT) protein is combined with a halide and a carbon source in a cultivation medium under conditions in which methyl formate is produced. The cell may genetically modified to express methyl formate synthase, methanol dehydrogenase and/or hydrolytic dehalogenase at levels higher than a cell of the same species that is not genetically modified. The methyl formate may be collected and used in a variety of applications. The halide may be chlorine, bromine or iodine.Type: GrantFiled: July 22, 2010Date of Patent: May 26, 2015Assignee: The Regents of the University of CaliforniaInventors: Christopher A. Voigt, Travis S. Bayer
-
Publication number: 20150024954Abstract: The invention relates to aptamer-regulated, ligand-responsive nucleic acids, or “ampliSwitches,” and uses thereof. Particular embodiments include a ligand-responsive nucleic acid that comprises a primer sequence domain and an aptamer domain that is responsive to a ligand.Type: ApplicationFiled: May 27, 2014Publication date: January 22, 2015Applicant: CALIFORNIA INSTITUTE OF TECHNOLOGYInventors: Christina D. Smolke, Travis S. Bayer
-
Patent number: 8772464Abstract: The invention relates to aptamer-regulated, ligand-responsive nucleic acids, or “ampliSwitches,” and uses thereof. Particular embodiments include a ligand-responsive nucleic acid that comprises a primer sequence domain and an aptamer domain that is responsive to a ligand.Type: GrantFiled: February 9, 2006Date of Patent: July 8, 2014Assignee: California Institute of TechnologyInventors: Christina D. Smolke, Travis S. Bayer
-
Publication number: 20120258506Abstract: Disclosed is a process in which a recombinant organism, such as a yeast, expressing a heterologous S-adenosylmethionme (SAM)-dependent methyl halide transferase (MHT) protein is combined with a halide and a carbon source in a cultivation medium under conditions in which methyl formate is produced. The cell may genetically modified to express methyl formate synthase, methanol dehydrogenase and/or hydrolytic dehalogenase at levels higher than a cell of the same species that is not genetically modified. The methyl formate may be collected and used in a variety of applications. The halide may be chlorine, bromine or iodine.Type: ApplicationFiled: July 22, 2010Publication date: October 11, 2012Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Christopher A. Voigt, Travis S. Bayer
-
Publication number: 20120035065Abstract: The invention relates to aptamer-regulated, ligand-responsive nucleic acids, or “ampliSwitches,” and uses thereof. Particular embodiments include a ligand-responsive nucleic acid that comprises a primer sequence domain and an aptamer domain that is responsive to a ligand.Type: ApplicationFiled: February 9, 2006Publication date: February 9, 2012Applicant: California Institute of TechnologyInventors: Christina D. Smolke, Travis S. Bayer
-
Publication number: 20110165618Abstract: The invention relates to systems and methods for production of compounds by yeast and other organisms. In one approach yeast engineered for production of a compound of commercial value is cultured together with a cellulosic bacteria, and the yeast uses a metabolic product produced by the bacteria as a carbon source. Methyl halides are an example of compounds that may be produced by this process. The invention also relates to production of organic compounds using genetically engineered organisms expressing a S-adenosylmethionine (SAM)-dependent methyl halide transferase. In one approach the organism, halides and a carbon source are incubated in a cultivation medium under conditions in which methyl halide is produced. The methyl halide may be collected and converted into non-halogenated organic molecules.Type: ApplicationFiled: November 26, 2008Publication date: July 7, 2011Inventors: Christopher A. Voigt, Travis S. Bayer
-
Publication number: 20110151534Abstract: The invention relates to a process for production of organic compounds using genetically engineered organisms expressing a S-adenosylmethionine (SAM)-dependent methyl halide transferase and, optionally modified at loci that affect flux through SAM metabolic pathways or affect intracellular halide levels. In one approach the organism, halides (chlorine, bromine and/or iodine); and a carbon source are incubated in a cultivation medium under conditions in which methyl halide is produced. The methyl halide may be collected and converted into non-halogenated organic molecules.Type: ApplicationFiled: November 26, 2008Publication date: June 23, 2011Inventors: Christopher A. Voigt, Daniel V. Santi, Travis S. Bayer